An IdeaNavigator AI listing proposes monitoring health and safety news for consumer brands, using a kidney-donation anniversary story as an example.
Browsing Category
Healthcare operations
31 posts
Making Lab And Symptom Tracking Part Of TRT Care
An IdeaNavigator AI concept proposes linking TRT patients’ lab results, dose changes and symptom check-ins; user demand remains untested.
A US Pharmacy Index For Brand-Name GLP-1 Access
A proposed US pharmacy index would compare dose availability and cash prices for four brand GLP-1 drugs, with a free patient tool and paid business feed.
The Future Of Drug Discovery: AI Partnerships And Funding Trends To Watch
Novo Nordisk partners with Anthropic; Anew Labs raises $290M, signaling mainstream shift of AI in pharma R&D and impacting markets.
Assessing The Strength Of Your Remote Workforce For Better Wellness
New remote work strength tests aim to identify early musculoskeletal risks in employees, helping employers prevent costly health issues.
Wellness Signal Monitor: Coroner Suspects Measles In Pa. Woman’s Death
Pennsylvania coroner suspects measles caused the death of an unvaccinated woman, pending further testing. The case raises concerns about vaccine coverage.
How Digital Benefit Check Bots Are Transforming Social Determinants Of Health
AI-powered benefit check bots are now enabling faster, more accurate screening for low-income programs, filling a critical gap after nonprofit closures and pandemic-driven redeterminations.
AZ Leans On AI-generated Llama To Promote LAMA Combo Inhaler Breztri In New Campaign
AstraZeneca has launched a new marketing campaign for Breztri inhaler featuring AI-generated llama imagery, signaling innovative use of AI in pharma advertising.
What Healthcare Organizations Need To Know About Integrating EHR Data With ChatGPT
OpenAI announces that healthcare organizations can now connect EHR systems to ChatGPT, raising questions about deployment, privacy, and clinical safety.
The Latest In Cancer Care: FDA Approves First Targeted Therapy For Pancreatic Cancer
The FDA has approved the first targeted therapy for metastatic pancreatic cancer, marking a significant advance in treatment options for this aggressive disease.